Morgan Stanley Maintains 1Q:11E EPS On WCRX

Morgan Stanley is maintaining its 1Q11E EPS of $0.84 on shares of Warner Chilcott WCRX. “WCRX raised its 2011 EPS guidance following debt refinancing on 3/17,” Morgan Stanley writes. “It also stated in an 8-K on 3/9 that ‘2011 total revenue and cash net income will be relatively lower in [1Q] and ramp up over the course of 2011 based on…a number of factors, including the launch of…Atelvia and Lo Loestrin Fe.' “We are raising our 2011E EPS from $3.53 to $3.70, 2% above consensus' $3.63.” Morgan Stanley said that its quarterly EPS progression in ‘11 is $0.84, $0.91, $0.93, and $1.02. Warner Chilcott closed Monday at $24.02.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst RatingsHealth CareMorgan StanleyPharmaceuticalswarner chilcott
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!